Strattera® (atomoxetine) is an atypical antidepressant medication used to treat Attention Deficit Hyperactivity Disorder (ADHD) and Social Anxiety Disorder (SAD/SAD-). Unlike traditional stimulant medications, Strattera® works by increasing the levels of certain chemicals in the brain.
The chemical imbalance can lead to various symptoms, such as agitation, poor concentration, impulsivity, and irritability. It can also affect focus, attention, and impulsivity.
The medication Strattera is often prescribed for ADHD, but its effectiveness varies from person to person. Some people may find it helpful to only take the medication once a day, while others may be prescribed an additional dose.
Strattera is approved for use in adults, but it can’t be used for children or adolescents under 18 years old. However, doctors may prescribe it for adults with ADHD.
A common side effect is difficulty concentrating, which can be particularly bothersome when starting a new medication. Some people may experience drowsiness or fatigue after taking Strattera, which can be particularly difficult to manage.
It’s important to take Strattera as directed and to report any unusual symptoms right away. Regular monitoring of your mood and behavior is essential during treatment.
is the generic name of atomoxetine, which is also sold under the brand name Strattera®. Unlike stimulant medications, which work by increasing the levels of certain chemicals in the brain, Strattera® is often prescribed for ADHD and Social Anxiety Disorder. Strattera is available as an immediate-release medication, while Strattera® is available as an extended-release medication.
This article aims to provide you with information on how to safely take Strattera.
To safely take Strattera, follow these steps:
To reduce the risk of drowsiness and enhance your ability to concentrate well, try to relax during the day. For example, try to work up to 4 hours before bed and at least 4 hours after eating. Use a rest routine containing rest, sedatives, and relaxation medications like Adderall or Lunesta to help reduce your risk of drowsiness.
Like any medication, Strattera can cause side effects, but some common ones are:
Dry mouth
Constipation
Dizziness
Headache
Increased appetite
Nausea or vomiting
Trouble sleeping
Nervousness or mood swings
These side effects usually go away as your body adjusts to the medication. However, if they persist or become bothersome, talk to your healthcare provider.
Strattera is not a controlled substance, but it can cause side effects.
Strattera is a medication used in adults to treat ADHD and narcolepsy. It is also used to treat depression and attention deficit hyperactivity disorder (ADHD).
Manufacturer:Bayer
AstraZeneca
DIN:
This product is a generic form of Strattera.
What is Strattera?
Strattera is a prescription medicine used to treat attention deficit hyperactivity disorder (ADHD) in children and adults.
How Strattera Works
Strattera works by increasing the levels of norepinephrine in the brain. This increases the activity of dopamine in the brain, which helps in hyperactivity, impulsiveness and irritability in children and adults.
How to Take Strattera
Strattera comes in two doses:
A tablet is usually taken 1-2 hours before a meal to reduce the amount of food eaten. Take this medication at around the same time each day.
Side Effects
Some side effects of Strattera may occur, such as:
If any side effects persist or become bothersome, talk to your doctor.
Drug Interactions
Some drugs, such as certain antidepressants (SNRIs and ) may interact with Strattera. This can cause drowsiness, dizziness, weakness, and confusion. You should avoid driving or operating machinery until you know how Strattera affects you.
Important Safety Information
How long does Strattera stay in your system?
Strattera may stay in your system for up to 2 weeks after you start taking it. However, this does not mean that you have a continuous erection. If you have trouble getting or keeping an erection, or if you have trouble keeping an erection, you should talk to your doctor about changing your medication or talking with your doctor about changing your dosage.
How long should I take Strattera?
Strattera is not recommended to be taken with other medications for ADHD. Before you take Strattera, talk to your doctor if you have any allergies, other conditions, or medical conditions, such as a,,, or or heart problems.
(Generic Name: Tatomox) is a selective norepinephrine reuptake inhibitor (SNRI) medication designed to treat attention-deficit hyperactivity disorder (ADHD) and other psychiatric conditions. Unlike traditional ADHD medications, Strattera is not a stimulant. Instead, it helps improve concentration, focus, and impulse control in children with ADHD.
Strattera works by increasing the levels of norepinephrine, a neurotransmitter in the brain that helps regulate attention, focus, and impulse control. This increased sensitivity helps improve attention, concentration, and impulse control, thereby enhancing focus and sustaining attention without impairing daily activities.
Strattera is approved for pediatric use in adults and children over 12 years of age. The medication is not approved for pediatric use in children under 12 years of age.
Strattera selectively inhibits norepinephrine reuptake but has a more modest impact on the neurotransmitter norepinephrine. By increasing norepinephrine levels, Strattera helps improve attention, concentration, and impulse control.
How Does Strattera Work?
Strattera (Tatomox) works by increasing the levels of norepinephrine, a neurotransmitter in the brain that helps regulate attention, focus, and impulse control. This increase in norepinephrine helps improve attention without impairing daily activities.
Strattera: An Overview
Strattera (Tatomox) is a medication that belongs to the class of drugs calledselective norepinephrine reuptake inhibitors (SNRIs). By inhibiting the reuptake of norepinephrine by neurons, Strattera helps reduce hyperactivity and impulsivity in children with ADHD.
Strattera (Tatomox) is a prescription medication that is primarily used for the treatment of attention-deficit hyperactivity disorder (ADHD).
It works by increasing the levels of norepinephrine, a neurotransmitter in the brain that helps regulate attention, concentration, and impulse control. This neurotransmitter helps improve attention without impairing daily activities.
Strattera (Tatomox) selectively inhibits norepinephrine reuptake but has a more modest impact on the neurotransmitter norepinephrine. By increasing norepinephrine levels, Strattera helps improve attention without impairing daily activities.
Strattera (Tatomox) works by increasing the levels of norepinephrine, a neurotransmitter in the brain that helps regulate attention, concentration, and impulse control. This increased sensitivity helps improve attention without impairing daily activities.
The National Institute for Mental Health (NIMH), a national nonprofit mental health agency, issued a press release today that said: “The drug Strattera may be a game-changer in treating Attention Deficit Hyperactivity Disorder (ADHD). Strattera has been shown to improve symptoms and to lower the risk of ADHD in adults who take it. It has also been shown to improve the symptoms of other conditions.
“The drug has been shown to increase energy and reduce impulsivity in children and adults with ADHD,” Dr. Joseph Leach said. “This may lead to improved mental health and mood.”
“While it has been shown to improve symptoms, it is not a cure, and there is not enough evidence to support a benefit,” he said. “This information may help physicians make more informed decisions about the use of Strattera.”
A study published in the Journal of the American Academy of Child and Adolescent Psychiatry found that a combination of atomoxetine and clomipramine (brand name Brisdelle) decreased ADHD symptoms by 40% and 60% in children and adults, respectively, compared with a placebo. The study also found that atomoxetine treatment improved the symptoms of ADHD in children. The medication was found to be effective in treating ADHD in children with both ADHD and the presence of comorbid psychiatric conditions such as major depressive disorder, anxiety disorders and panic disorders. The drug also appears to help a child with ADHD who is unable to tolerate or cannot tolerate the side effects of atomoxetine.
“It is important to note that these findings need to be interpreted carefully, as there is a need for further research into the use of atomoxetine in children and adults,” Dr. Leach said. “These findings are important for both the health care system and the public health system to understand.”
“This information is important because it will be important to see whether the use of atomoxetine by children and adults is safe and effective,” he said. “The data presented here should inform both physicians and patients, and to make decisions about prescribing, dispensing and marketing atomoxetine for children and adults.
“In this way, we can work together to achieve the best possible outcomes, as well as the best use of this drug in the future,” he said.
Dr. Leach has served as an advisor to NIMH, and is a consultant to both the National Institute of Mental Health and the Pharmaceutical Research Institute.
Copyright © 2025 NIMH. All rights reserved.Product Code: E45-097-B1-9Get access to free access to our new online catalog, free of charge, from the National Library of Medicine website.
https://www.lil.com/product/product_code/E45-097-B1-9Get access to our new online catalog, free of charge, from the National Library of Medicine website.
https://www.Atomoxetine is a medication approved by the Food and Drug Administration (FDA) for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children and adolescents from eight to 14 years of age. It belongs to a class of drugs known as atypical antipsychotics.
Atomoxetine is a non-benzodiazepine selective norepinephrine reuptake inhibitor. It works by increasing the levels of norepinephrine in the brain.
Atomoxetine is used for treating the following conditions in children and adolescents aged 6 months to 17 years:
Atomoxetine is also used to treat the following conditions in adults:
Atomoxetine is not approved by the FDA to treat ADHD, but some other medications are also used to treat ADHD. For example, it is used as a medication for the treatment of ADHD in children and adolescents, but it is not approved for use in children.
What is Atomoxetine?
Atomoxetine is a medication classified as a selective norepinephrine reuptake inhibitor (SNRI).
Mechanism of Action:
Atomoxetine has a unique action mechanism:It increases the levels of norepinephrine and dopamine in the brain. It also affects other neurotransmitters like serotonin and norepinephrine.
Indications:Atomoxetine is approved for the treatment of attention-deficit/hyperactivity disorder, narcolepsy, and in the management of symptoms of primary sleep disorders.
Dosage and Administration:Atomoxetine is available in oral, intramuscular, intravenous, and intravenous forms.
Side Effects:The most common side effects include drowsiness, fatigue, insomnia, and insomnia.
FDA Approval:
Atomoxetine increases the levels of norepinephrine and dopamine in the brain.